Geode Capital Management, LLC Axsome Therapeutics, Inc. Transaction History

Geode Capital Management, LLC

  • $1.24 Trillion
  • Q1 2025

A detailed history of Geode Capital Management, LLC transactions in Axsome Therapeutics, Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 934,853 shares of AXSM stock, worth $105 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
934,853
Previous 912,538 2.45%
Holding current value
$105 Million
Previous $77.2 Million 41.22%
% of portfolio
0.01%
Previous 0.01%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 13, 2025
BUY
$80.05 - $137.75 $1.79 Million - $3.07 Million
22,315 Added 2.45%
934,853 $109 Million
Q4 2024

Feb 12, 2025
BUY
$83.08 - $100.49 $338,883 - $409,898
4,079 Added 0.45%
912,538 $77.2 Million
Q3 2024

Nov 12, 2024
BUY
$78.93 - $95.84 $1.86 Million - $2.26 Million
23,564 Added 2.66%
908,459 $81.6 Million
Q2 2024

Aug 09, 2024
BUY
$65.72 - $80.5 $2.6 Million - $3.18 Million
39,488 Added 4.67%
884,895 $71.2 Million
Q1 2024

May 13, 2024
BUY
$69.39 - $97.64 $1.6 Million - $2.26 Million
23,103 Added 2.81%
845,407 $67.5 Million
Q4 2023

Feb 13, 2024
BUY
$57.42 - $83.61 $2.52 Million - $3.66 Million
43,809 Added 5.63%
822,304 $65.4 Million
Q3 2023

Nov 13, 2023
BUY
$69.25 - $82.21 $4.76 Million - $5.65 Million
68,727 Added 9.68%
778,495 $54.4 Million
Q2 2023

Aug 11, 2023
BUY
$58.41 - $90.35 $3.35 Million - $5.18 Million
57,332 Added 8.79%
709,768 $51 Million
Q1 2023

May 15, 2023
BUY
$58.39 - $75.0 $1.63 Million - $2.09 Million
27,847 Added 4.46%
652,436 $40.2 Million
Q4 2022

Feb 13, 2023
BUY
$39.94 - $79.72 $2.48 Million - $4.94 Million
62,000 Added 11.02%
624,589 $48.2 Million
Q3 2022

Nov 14, 2022
BUY
$36.06 - $69.85 $1.11 Million - $2.15 Million
30,837 Added 5.8%
562,589 $25.1 Million
Q2 2022

Aug 12, 2022
SELL
$21.74 - $46.75 $92,873 - $199,716
-4,272 Reduced 0.8%
531,752 $20.4 Million
Q1 2022

May 13, 2022
BUY
$23.7 - $41.39 $676,374 - $1.18 Million
28,539 Added 5.62%
536,024 $22.2 Million
Q4 2021

Feb 11, 2022
BUY
$30.7 - $43.36 $492,888 - $696,144
16,055 Added 3.27%
507,485 $19.2 Million
Q3 2021

Nov 12, 2021
BUY
$19.91 - $68.26 $162,863 - $558,366
8,180 Added 1.69%
491,430 $16.2 Million
Q2 2021

Aug 13, 2021
BUY
$50.63 - $73.5 $742,387 - $1.08 Million
14,663 Added 3.13%
483,250 $32.6 Million
Q1 2021

May 12, 2021
BUY
$55.91 - $81.44 $2.31 Million - $3.36 Million
41,286 Added 9.66%
468,587 $26.5 Million
Q4 2020

Feb 12, 2021
BUY
$66.31 - $86.52 $646,190 - $843,137
9,745 Added 2.33%
427,301 $34.8 Million
Q3 2020

Nov 13, 2020
SELL
$68.34 - $85.84 $569,477 - $715,304
-8,333 Reduced 1.96%
417,556 $29.8 Million
Q2 2020

Aug 13, 2020
BUY
$49.87 - $98.69 $730,046 - $1.44 Million
14,639 Added 3.56%
425,889 $35 Million
Q1 2020

May 14, 2020
BUY
$41.2 - $101.31 $1.78 Million - $4.38 Million
43,229 Added 11.75%
411,250 $24.2 Million
Q4 2019

Feb 13, 2020
BUY
$16.71 - $106.24 $407,473 - $2.59 Million
24,385 Added 7.1%
368,021 $38 Million
Q3 2019

Nov 12, 2019
BUY
$20.24 - $29.16 $789,339 - $1.14 Million
38,999 Added 12.8%
343,636 $6.96 Million
Q2 2019

Aug 14, 2019
BUY
$13.46 - $25.75 $1.91 Million - $3.66 Million
142,183 Added 87.52%
304,637 $7.84 Million
Q1 2019

May 14, 2019
BUY
$2.63 - $16.34 $179,494 - $1.12 Million
68,249 Added 72.45%
162,454 $2.31 Million
Q3 2017

Nov 14, 2017
BUY
$4.65 - $6.1 $100,026 - $131,217
21,511 Added 29.59%
94,205 $522,000
Q2 2017

Aug 14, 2017
BUY
N/A
72,694
72,694 $399,000

Others Institutions Holding AXSM

# of Institutions
408
Shares Held
36.1M
Call Options Held
751K
Put Options Held
568K
View Full List

About Axsome Therapeutics, Inc.

AXSM Quotes by TradingView
  • Ticker AXSM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 42,878,000
  • Market Cap $4.81B
  • Description
  • Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...
More about AXSM
Track This Portfolio

Track Geode Capital Management, LLC Portfolio

Follow Geode Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email